Breast cancer is one of the most common diseases in women. Early detection has relied on the results of mammography for many years. This methodology is not without controversy. Nevertheless, researchers are looking at specific treatments and a new methodology that has the potential of predicting the risk of breast cancer. This valuable information may be able to predict the occurrence of breast cancer several years into the future, which could save the lives of hundreds of women.
An avid approach to conquering the prevention or early detection of breast cancer, is of great importance to women for very necessary reasons. First, it is evident that women are living longer. Secondly, there is a concern regarding the over treatment of breast cancer. Data published in the Journal of National Cancer Institute documented there were no differences in the survival rates that occurred 20 years after being diagnosed, from women whose unaffected breast was removed and those who did not.
Recently, at the annual meeting of the American Association of Cancer Research, it was reported that a dietary change can have an impact on the risk of breast cancer in women. Researchers from the University of California, San Diego Medical School reported in the Cancer Epidemiology, Biomarkers, & Prevention journal increasing the nighttime absence of food can reduce blood glucose concentration levels, which may be related to developing breast cancer. The data demonstrated for every three-hour increase of nighttime fasting, there was a four percent lower after-eating-a-meal glucose level.
The women, who participated in this study, ate five times a day with limitations placed on the amount of red meat, alcohol, and refined grains consumed. Additionally, it was advised to increase the among of plant-based foods. The average length of nighttime fasting was 12 hours. Commensurate with the study, Dr. Ruth Patterson, program director at the UC San Diego Moores Cancer Center and the associate director for population sciences, added that how often and when people eat may affect the risk of cancer. It is recommended that the study of the affects of glucose levels after eating provide research on a larger scale.
Cancer researchers continue to examine the affect of a drug combination that can address the relapse of breast cancer or treatment resistance. For the most common type of breast cancer that affects more than 70 percent of women, Sulforadex has been successful for overcoming resistance along with hormonal therapy by targeting the stem cell, which was also reported by researchers at the annual meeting of the American Association of Cancer Research.
Approximately, 70 percent of breast cancer victims receive treatment that focuses on the reduction of estrogen or blocking estrogen receptors. This combination of Sulforadex with standard hormonal treatments is being tested at the University of Manchester lab studies to identify how the drug targets cancer in estrogen sensitive cells and the remaining the cancer stem cells
There is a new method being studied for futuristic predictions of breast cancer that requires techniques performed during a blood test. The success of determining the likelihood of its occurrence is by the data supported from the blood test, which may, also, lead to a significant breakthrough for other diseases. Researchers at the University of Copenhagen, Denmark have described the process as examining the information provided by compounds in the blood.
The study, conducted by the Danish Cancer Society, used blood samples from 57,053 women and men over a 20 year period of time for this breast cancer study. Additionally, more than 400 other women, who had been diagnosed with cancer, gave a sample two to five years after being diagnosed. Although this method of providing future predictions of breast cancer is still in its infancy stages of use and technique, its credibility has been touted at 80 percent in comparison to 75 percent provided by a mammography exam.
Written by Marie A. Wakefield